We are live on ! Find out more
PM

Penbrook Management Portfolio holdings

AUM $157M
1-Year Est. Return 46.57%
This Fund
S&P 500
This Quarter Est. Return
+11.99%
1 Year Est. Return
+46.57%
3 Year Est. Return
+105.97%
5 Year Est. Return
+154.19%
10 Year Est. Return
–
AUM
$103M
AUM Growth
–
Cap. Flow
+$98.2M
Cap. Flow %
95.28%
Top 10 Hldgs %
26.91%
Holding
111
New
111
Increased
–
Reduced
–
Closed
–
Avg Time Held
0 quarters
Top 10 Avg Time Held
0 quarters
Top 20 Avg Time Held
0 quarters

Top Buys

Rank Stock Value
1
NVO icon
Novo Nordisk
NVO
+$4.43M
2
MSFT icon
Microsoft
MSFT
+$2.97M
3
FEIC
FEI COMPANY
FEIC
+$2.86M
4
HBIO icon
Harvard Bioscience
HBIO
+$2.45M
5
CLMT icon
Calumet Specialty Products
CLMT
+$2.34M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 28.52%
2 Healthcare 16.78%
3 Energy 13.93%
4 Financials 12.08%
5 Miscellaneous 10.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
NVO icon
1
Novo Nordisk
NVO
$171B
$4.69M 4.55%
+254,000
New +$4.43M
2013 Q4
0 quarters
MSFT icon
2
Microsoft
MSFT
$3.97T
$3.06M 2.97%
+81,744
New +$2.97M
2013 Q4
0 quarters
FEIC
3
DELISTED
FEI COMPANY
FEIC
$2.88M 2.79%
+32,230
New +$2.86M
2013 Q4
0 quarters
FNF icon
4
Fidelity National Financial
FNF
$10.4B
$2.67M 2.59%
+144,161
New +$2.33M
2013 Q4
0 quarters
HBIO icon
5
Harvard Bioscience
HBIO
$37.5M
$2.63M 2.55%
+56,001
New +$2.45M
2013 Q4
0 quarters
AFFX
6
DELISTED
Affymetrix Inc
AFFX
$2.61M 2.53%
+304,500
New +$2.33M
2013 Q4
0 quarters
EPAY
7
DELISTED
Bottomline Technologies Inc
EPAY
$2.47M 2.39%
+68,260
New +$2.21M
2013 Q4
0 quarters
CLB icon
8
Core Laboratories
CLB
$463M
$2.33M 2.26%
+12,208
New +$2.27M
2013 Q4
0 quarters
SHOR
9
DELISTED
ShoreTel, Inc.
SHOR
$2.21M 2.15%
+238,450
New +$1.8M
2013 Q4
0 quarters
CLMT icon
10
Calumet Specialty Products
CLMT
$4.96B
$2.17M 2.11%
+83,581
New +$2.34M
2013 Q4
0 quarters
BTE icon
11
Baytex Energy
BTE
$3.36B
$2.08M 2.02%
+53,223
New +$2.14M
2013 Q4
0 quarters
PRCP
12
DELISTED
Perceptron Inc
PRCP
$2.04M 1.98%
+147,058
New +$1.73M
2013 Q4
0 quarters
GOOG icon
13
Alphabet (Google) Class C
GOOG
$4.25T
$1.9M 1.85%
+68,175
New +$1.72M
2013 Q4
0 quarters
MCO icon
14
Moody's
MCO
$80.4B
$1.9M 1.84%
+24,200
New +$1.77M
2013 Q4
0 quarters
ECPG icon
15
Encore Capital Group
ECPG
$2.12B
$1.85M 1.79%
+36,784
New +$1.75M
2013 Q4
0 quarters
IMMR icon
16
Immersion
IMMR
$247M
$1.8M 1.74%
+173,236
New +$2.12M
2013 Q4
0 quarters
LGCY icon
17
DELISTED
Legacy Reserves Inc. Common Stock
LGCY
$1.76M 1.71%
+62,490
New +$1.72M
2013 Q4
0 quarters
SNPS icon
18
Synopsys
SNPS
$97.7B
$1.69M 1.64%
+41,650
New +$1.56M
2013 Q4
0 quarters
XCRA
19
DELISTED
Xcerra Corporation
XCRA
$1.62M 1.58%
+203,284
New +$1.39M
2013 Q4
0 quarters
ARRS
20
DELISTED
ARRIS International plc Ordinary Shares
ARRS
$1.52M 1.48%
+62,482
New +$1.19M
2013 Q4
0 quarters
IRBT icon
21
DELISTED
iRobot
IRBT
$1.49M 1.44%
+42,700
New +$1.46M
2013 Q4
0 quarters
NUAN
22
DELISTED
Nuance Communications, Inc.
NUAN
$1.47M 1.43%
+111,891
New +$1.54M
2013 Q4
0 quarters
DAIO icon
23
Data I/O
DAIO
$30.3M
$1.38M 1.34%
+537,250
New +$1.5M
2013 Q4
0 quarters
TER icon
24
Teradyne
TER
$63B
$1.34M 1.3%
+76,080
New +$1.29M
2013 Q4
0 quarters
VIVS icon
25
VivoSim Labs
VIVS
$2.41M
$1.33M 1.29%
+500
New +$981K
2013 Q4
0 quarters
1
2 3 4 5

Similar funds

AFW
Avantra Family Wealth Mechanicsburg, Pennsylvania $157M AUM 35.53% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $157M AUM 29.28% 1-Year Est. Return
AWA
Authentikos Wealth Advisory Morgan Hill, California $157M AUM 21.34% 1-Year Est. Return
BGAI
Bruce G. Allen Investments Denver, Colorado $157M AUM 28.14% 1-Year Est. Return
AIG
Abbington Investment Group Westport, Connecticut $157M AUM 35.92% 1-Year Est. Return
MFG
Mosaic Financial Group Chicago, Illinois $156M AUM 23.77% 1-Year Est. Return
BCM
Bayesian Capital Management Brooklyn, New York $156M AUM 14.89% 1-Year Est. Return
MCM
Mork Capital Management Healdsburg, California $156M AUM 39.85% 1-Year Est. Return

Penbrook Management's Q4 2013 Portfolio in Review

Q4 2013 is the first quarter with a 13F filing on record for Penbrook Management, which disclosed 111 positions worth $103M. Its ten largest holdings account for 27% of the portfolio.

Its largest position is Novo Nordisk: 254,000 shares worth $4.69M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, followed by Healthcare and Energy.

  • Penbrook Management's largest Q4 2013 buy was Novo Nordisk: 254,000 shares worth $4.69M.
  • Penbrook Management's ten largest holdings make up 27% of its $103M portfolio in Q4 2013.
  • Penbrook Management disclosed 111 positions in Q4 2013, its first 13F filing on record.

Based on Penbrook Management's 13F filing for Q4 2013, filed 25 Mar 2014.